Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines

Oncology Letters

Volumn 7, Issue 5, 2014, Pages 1581-1585

  Wang, Hui ^a,b   Liu, Wenli ^c   Wei, Dongmin ^c   Hu, Kun ^b   Wu, Xiaohua ^d   Yao, Yuanqing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Department of Obstetrics and Gynaecology Shijingshan Teaching Hospital of Capital Medical University Beijing Shijingshan Hospital ^*  (China)

^c HEBEI UNIVERSITY OF ENGINEERING   (China)

^d BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

CXCL12 CXCR4 axis; Lysophosphatidic acid; Metastasis; Ovarian neoplasm

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MTT ASSAY; OVARY CANCER; PERITONEUM METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84896283187     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1926     Document Type: Article

References (27)

1. Xu Y, Gaudette DC, Boynton JD, et al: Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin Cancer Res 1: 1223-1232, 1995.
2. Xu Y, Shen Z, Wiper DW, et al: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280: 719-723, 1998.
3. Hu YL, Albanese C, Pestell RG and Jaffe RB: Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J Natl Cancer Inst 95: 733-740, 2003.
4. Frankel A and Mills GB: Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells. Clin Cancer Res 2: 1307-1313, 1996.
5. Pustilnik TB, Estrella V, Wiener JR, et al: Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res 5: 3704-3710, 1999.
6. Fujita T, Miyamoto S, Onoyama I, Sonoda K, Mekada E and Nakano H: Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer. Cancer Lett 192: 161-169, 2003.
7. Fishman DA, Liu Y, Ellerbroek SM and Stack MS: Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res 61: 3194-3199, 2001.
8. So J, Navari J, Wang FQ and Fishman DA: Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8. Gynecol Oncol 95: 314-322, 2004.
9. Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG and Stack MS: Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res 65: 2234-2242, 2005.
10. Scotton CJ, Wilson JL, Milliken D, Stamp G and Balkwill FR: Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61: 4961-4965, 2001.
11. Scotton CJ, Wilson JL, Scott K, et al: Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62: 5930-5938, 2002.
12. Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M and Yamamoto N: Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 60: 273-276, 2006.
13. Jiang YP, Wu XH, Shi B, Wu WX and Yin GR: Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 103: 226-233, 2006.
14. Jemal A, Thomas A, Murray T and Thun M: Cancer statistics, 2002. CA Cancer J Clin 52: 23-47, 2002.
15. Popple A, Durrant LG, Spendlove I, et al: The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br J Cancer 106: 1306-1313, 2012.
16. Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
17. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP and Strieter RM: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167: 1676-1686, 2003.
18. Cooper CR, Chay CH, Gendernalik JD, et al: Stromal factors involved in prostate carcinoma metastasis to bone. Cancer 97 (3 Suppl): 739-747, 2003.
19. Kryczek I, Wei S, Keller E, Liu R and Zou W: Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292: C987-C995, 2007.
20. Guo L, Cui ZM, Zhang J and Huang Y: Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma. Chin J Cancer 30: 336-343, 2011.
21. Daaka Y: Mitogenic action of LPA in prostate. Biochim Biophys Acta 1582: 265-269, 2002.
22. Gräler MH and Goetzl EJ: Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim Biophys Acta 1582: 168-174, 2002.
23. Ren J, Xiao YJ, Singh LS, et al: Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res 66: 3006-3014, 2006.
24. Moolenaar WH: Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 253: 230-238, 1999.
25. Ishii S, Noguchi K and Yanagida K: Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 89: 57-65, 2009.
26. Yanagida K, Kurikawa Y, Shimizu T and Ishii S: Current progress in non-Edg family LPA receptor research. Biochim Biophys Acta 1831: 33-41, 2013.
27. Gunther EC, von Bartheld CS, Goodman LJ, Johnson JE and Bothwell M: The G-protein inhibitor, pertussis toxin, inhibits the secretion of brain-derived neurotrophic factor. Neuroscience 100: 569-579, 2000.